Use access key #2 to skip to page content.
$26.63 -1.88 (-6.59%)
8/20/2008 3:31 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar InvestorDeb (80.97) Submitted: 6/30/08 9:21 AM : Outperform Start Price: $26.42 AMLN Score: 6.45

I thought the recent pullback was overdone. No money here, just a caps pick for me.

Report this Post Replies: 0 | Reply

Featured Broker Partners